Mantle cell lymphoma: Full guide

What is mantle cell lymphoma?

Mantle cell lymphoma (MCL) is a cancer of B cells. B cells are white blood cells that make antibodies to fight infection. The cancer starts in B cells from the outer ring, or "mantle," of a lymph node.

It is uncommon. It makes up about 5 out of 100 non-Hodgkin lymphomas. It is more common in men and in people over 60.

MCL often involves many lymph nodes, the spleen, the bone marrow, and the blood when it is found. It can also involve the stomach and bowels. Some people have swollen lymph nodes, tiredness, fevers, night sweats, or weight loss. Others have no symptoms.

MCL acts very differently in different people. Some forms grow slowly and can be watched for a while. Others grow fast and need treatment right away. For most people it is not cured with today's treatments, but it can often be controlled for many years. Treatments have improved a lot in the last 10 years.

Types and how it behaves

Classic MCL

The most common form. It usually involves lymph nodes and often other areas. Most people need treatment soon after diagnosis.

Leukemic non-nodal MCL

A slower form. It is mainly in the blood, bone marrow, and sometimes the spleen, with few or no large lymph nodes. Some people with this form can watch and wait, sometimes for years.

Blastoid and pleomorphic MCL

Forms where the cells look larger and more abnormal under the microscope. They grow faster and are harder to treat.

Early-stage MCL

Rarely, MCL is found in only one or two areas. Radiation, sometimes with other treatment, may be used.

In situ mantle cell neoplasm

Very early MCL-like cells found by chance inside a normal lymph node. It rarely turns into lymphoma and usually only needs follow-up.

Tests you may have

Biopsy

A doctor removes a lymph node, or a piece of it, to look at under a microscope. Special stains confirm that it is MCL.

PET-CT scan

A scan that uses a small amount of a sugar-like tracer. It shows where the lymphoma is and later shows how well treatment worked.

Blood tests

These check blood counts, liver and kidney health, and LDH (a protein that can be high when lymphoma is active). A test called flow cytometry can find MCL cells in the blood.

Bone marrow biopsy

A needle takes a small sample from the back of the hip bone. MCL is often in the marrow, so this test is commonly done.

Hepatitis B, hepatitis C, and HIV tests

Rituximab and similar drugs can wake up a hidden hepatitis B infection. If you have had hepatitis B, you may take a pill to prevent this.

Endoscopy and colonoscopy

A thin tube with a camera looks at the stomach or bowels. It may be done if you have stomach symptoms, or before some treatment plans, because MCL often hides there.

Lumbar puncture (spinal tap)

A thin needle takes fluid from the lower back. It may be done for blastoid MCL or if there are nerve symptoms, to check for spread to the brain or spinal cord.

Heart test (echocardiogram)

An ultrasound of the heart. It is done before drugs like doxorubicin. Your heart rhythm may also be checked before BTK inhibitor pills.

Stage and risk groups

The stage tells how far the lymphoma has spread. Most people with MCL have stage 3 or 4 when it is found, often with lymphoma in the bone marrow or blood. This is expected and does not mean treatment will not work.

Because stage alone does not tell the whole story, doctors also look at risk features. These help decide how strong treatment should be.

Stage 1

Lymphoma is in one lymph node area, or in one organ outside the lymph nodes.

Stage 2

Lymphoma is in two or more lymph node areas on the same side of the diaphragm. The diaphragm is the muscle under your lungs.

Stage 3

Lymphoma is in lymph nodes both above and below the diaphragm.

Stage 4

Lymphoma has spread more widely, such as into the bone marrow, blood, liver, or bowels. This is the most common stage in MCL.

MIPI score

A risk score based on age, how well you can do daily activities, LDH, and white blood cell count. It sorts people into low, middle, and high risk. Adding the Ki-67 result makes it more exact.

High-risk features

These include a TP53 gene change, a high Ki-67, and blastoid or pleomorphic cells. Lymphoma with these features tends to grow faster and come back sooner.

Gene and lab tests

Lab tests on your biopsy confirm MCL and look for features that predict how it will behave. These results help your care team choose between stronger and gentler treatment plans.

The most important test is for TP53. Ask your care team if it was checked, and what your results mean for your treatment.

Cyclin D1 and t(11;14)

Almost all MCL has a gene swap between chromosomes 11 and 14. It makes the cells make too much cyclin D1, a protein that pushes cells to divide. Finding it confirms the diagnosis.

CD5 and CD20

Markers on the surface of MCL cells. CD20 is the target for antibody drugs like rituximab.

SOX11

A protein seen in most classic MCL. When it is missing, the lymphoma is more often the slower, non-nodal form.

Ki-67

Shows how fast the cells are dividing. A high Ki-67 (30% or more) means faster growth.

TP53 change

A change in a gene that normally helps damaged cells die. It is the strongest high-risk feature in MCL. Chemotherapy works less well when it is present, so doctors favor other treatments or clinical trials.

Other gene changes

Changes in genes like CDKN2A, NOTCH1, and NSD2 may also mean higher risk. They are checked at some centers.

Main treatments

Watch and wait

For some people with slow-growing MCL and no symptoms, careful watching is safe. Treatment starts if the lymphoma begins to grow or cause problems.

Intensive treatment for younger, fit people

Stronger chemotherapy with rituximab, often including a drug called cytarabine. Examples are R-CHOP alternating with R-DHAP, or bendamustine with rituximab followed by rituximab with cytarabine. A BTK inhibitor pill is now often added.

Autologous stem cell transplant

High-dose chemotherapy followed by your own stem cells to rebuild the bone marrow. It has been part of standard care for younger, fit people. Newer research suggests some people treated with a BTK inhibitor may be able to skip it, so this is now a shared decision.

Less intensive treatment

For older people or those with other health problems. Bendamustine with rituximab is common, now often with the BTK inhibitor acalabrutinib. R-CHOP is another option. Some plans use no chemotherapy, such as a BTK inhibitor with rituximab.

Maintenance rituximab

Rituximab given every 2 to 3 months for a few years after first treatment. It helps keep MCL away longer, and after transplant it has helped people live longer.

BTK inhibitors

Pills that block a signal MCL cells need to grow. Examples are acalabrutinib and zanubrutinib. Pirtobrutinib works in a different way and can help even after another BTK inhibitor stops working. They are used in first treatment and when MCL comes back.

Treatment when TP53 is changed

Chemotherapy works less well. Doctors often use BTK inhibitors, sometimes with venetoclax or an antibody, and suggest clinical trials or CAR T-cell therapy earlier.

CAR T-cell therapy

Your own T cells (a type of immune cell) are collected and changed in a lab so they can find and kill MCL cells. They are given back through a vein. Examples are brexu-cel and liso-cel. It is used when MCL comes back, often after a BTK inhibitor.

Other options when it comes back

These include venetoclax, lenalidomide with rituximab, bispecific antibodies, and in some cases a donor (allogeneic) stem cell transplant. Clinical trials are a good option at any stage. Ask your care team if one fits you.

Common side effects and what helps

Infections

Treatment lowers your germ-fighting cells and antibodies, sometimes for months. Wash hands often and call right away for a fever. Ask about vaccines and medicines to prevent infections.

Low blood counts

Intensive chemotherapy and transplant can cause very low counts. You may need transfusions or shots to raise white blood cells.

Bleeding and bruising

BTK inhibitors can make you bruise or bleed more easily. Tell your care team before any surgery or dental work, and about any blood thinners you take.

Heart rhythm and blood pressure

BTK inhibitors can cause a fast or irregular heartbeat and high blood pressure. Your care team will check these. Call if your heart races or you feel faint.

Headache, diarrhea, and joint pain

These are common early on with BTK inhibitors and often get better. Tell your care team, since there are ways to manage them.

Infusion reactions

Rituximab can cause chills, fever, or rash, mostly with the first dose. You get medicines beforehand, and nurses watch you closely.

Tumor lysis syndrome

When many lymphoma cells die quickly, they can release salts that harm the kidneys. This is a concern with venetoclax and some other treatments. Drinking fluids, blood tests, and medicines help prevent it.

Cytokine release syndrome (CRS) and ICANS

After CAR T-cell therapy or bispecific antibodies, a strong immune reaction can cause fever and low blood pressure. Some people get confused or have trouble speaking. Caregivers should watch for this and call right away. People are told not to drive for a period of time after CAR T.

Living with mantle cell lymphoma

For many people, MCL is a long-term illness with times of treatment and times of remission. You will have regular check-ups and sometimes scans. Tell your care team about new lumps, fevers, sweats, weight loss, or stomach and bowel changes.

If you take a BTK inhibitor for a long time, keep a list of your medicines and share it with every doctor and pharmacist. Some medicines, foods, and supplements can change how these pills work or raise bleeding risk. Grapefruit and some herbal products are common examples.

Treatment can lower your defenses against infection for months. Ask which vaccines you need, such as flu, COVID-19, pneumonia, and shingles vaccines, and when to get them. Live vaccines are usually avoided during and after some treatments.

Because MCL is uncommon, care at or with input from a lymphoma center can help. It is normal to feel worried or low. Support groups, counselors, and social workers can help you and your family.